NUVA - NuVasive - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NuVasive's activity chart (see below) currently has 292 price targets and 193 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 55.1% with an average time for these price targets to be met of 142.24 days.

Most recent stock forecast was given by from BARCLAYS on 04-Aug-2023. First documented stock forecast 26-Feb-2010.

Best performing analysts who are covering NUVA - NuVasive:

Mike Matson William Plovanic Glenn Novarro Richard Newitter Kyle Rose

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 26-Feb-2010

$58

$18.25 (45.91%)

$56

3 years 2 months 4 days ago
(04-Aug-2023)

5/18 (27.78%)

$18.95 (48.53%)

546

$45

$5.25 (13.21%)

$40

3 years 2 months 4 days ago
(04-Aug-2023)

4/8 (50%)

$5.95 (15.24%)

28

Hold Since 14-Oct-2021

$45

$5.25 (13.21%)

$45

3 years 2 months 5 days ago
(03-Aug-2023)

0/3 (0%)

$5 (12.50%)

Hold Since 07-Oct-2022

$45

$5.25 (13.21%)

$54

3 years 2 months 5 days ago
(03-Aug-2023)

2/8 (25%)

$5 (12.50%)

32

Hold Since 11-May-2023

$51

$11.25 (28.30%)

$48

3 years 2 months 19 days ago
(19-Jul-2023)

14/20 (70%)

$7.86 (18.22%)

269

Show more analysts

Please expand the browser size to see the chart

What is NUVA (NuVasive) average time for price targets to be met?

On average it took 142 days for the stock forecasts to be reached, with an average price target met ratio of 55.1%.

Which analyst most recently updated their price target on NUVA (NuVasive)?

Which analyst has the most public recommendations on NUVA (NuVasive)?

has 0 price targets and 0 ratings on NUVA

Which analyst is the currently most bullish on NUVA (NuVasive)?

Craig Bijou with the highest potential upside of $45.25

Which analyst is the currently most reserved on NUVA (NuVasive)?

Ryan Zimmerman with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?